Ingevity (NGVT)
(Delayed Data from NYSE)
$37.46 USD
-0.43 (-1.13%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $37.46 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$37.46 USD
-0.43 (-1.13%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $37.46 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
POSCO Rides on Business Expansion Amid Volatile Exchange Rate
by Zacks Equity Research
POSCO's (PKX) performance will likely be affected by volatile exchange rate, despite focus on mergers and business expansion, strong demand and improvement in steel export.
Ashland (ASH) Releases Update on Fiscal 2019 Financial View
by Zacks Equity Research
Ashland (ASH) projects adjusted EPS for fiscal 2019 in the range of $3.10-$3.40, reflecting the pending divestiture of the Composites unit and the BDO manufacturing facility.
Reasons to Add Ingevity (NGVT) Stocks to Your Portfolio Now
by Zacks Equity Research
Solid growth prospects and upbeat outlook make Ingevity (NGVT) an attractive investment option.
ICL or NGVT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. NGVT: Which Stock Is the Better Value Option?
Ingevity (NGVT) Shares Up 17% YTD: What's Working in Favor?
by Anindya Barman
Let's take a look into the factors that are driving Ingevity (NGVT).
Ingevity (NGVT) to Buy Perstorp's Capa Caprolactone Unit
by Zacks Equity Research
Ingevity (NGVT) expects the acquisition to be immediately accretive to earnings in the first full year.
CE vs. NGVT: Which Stock Is the Better Value Option?
by Zacks Equity Research
CE vs. NGVT: Which Stock Is the Better Value Option?
LyondellBasell's Technology Selected for PP Plant in China
by Zacks Equity Research
LyondellBasell's (LYB) latest project marks the ninth Spherizone line license in China.
Ashland (ASH) Wraps Up HEC Expansion, Boosts Production
by Zacks Equity Research
Capacity expansion enables Ashland (ASH) to support increasing demand for Natrosol HEC.
Newmont Provides Updated Production & Cost Guidance for FY19
by Zacks Equity Research
Newmont (NEM) expects production in 2019 to be driven by higher grade production from the Subika Underground project in Africa.
Eastman Chemical's (EMN) Board Announces 11% Hike in Dividend
by Zacks Equity Research
Eastman Chemical (EMN) is committed towards balanced and disciplined capital allocation and shareholders returns.
Here's Why You Should Buy Celanese (CE) Stock Right Now
by Anindya Barman
Let's see what makes Celanese (CE) stock an attractive investment option at the moment.
Ingevity Starts Activated Carbon Production at Changshu Plant
by Zacks Equity Research
The new facility at Changshu allows Ingevity (NGVT) to meet the rising global demand for pelletized carbon products.
Here's Why You Should Hold Commercial Metals in Your Portfolio
by Zacks Equity Research
Commercial Metals (CMC) will benefit from improvement in farm equipment manufacturing activity, construction machinery and energy related spending.
Mosaic (MOS) Up 20% in 6 Months: What's Behind the Rally?
by Zacks Equity Research
Upbeat earnings outlook, bright prospects from the Vale Fertilizantes buyout and strong fertilizer market fundamentals drive Mosaic's (MOS) shares.
Ashland (ASH) Up 15% in a Year: What's Working in Favor?
by Anindya Barman
Strategic initiatives have contributed to the gain in Ashland's (ASH) shares.
Reasons to Hold International Flavors (IFF) in Your Portfolio
by Zacks Equity Research
International Flavors' (IFF) performance is likely to be supported by growth in the global market for flavors and fragrances despite adverse impacts of rising costs.
Here's Why Ingevity (NGVT) Stock is Worth Buying Right Now
by Anindya Barman
Let's see what makes Ingevity (NGVT) stock an attractive investment option at the moment.
US Specialty Chemicals Volumes Up in October: 3 Stocks to Buy
by Anindya Barman
While specialty chemical companies face headwinds from trade tensions and raw material inflation, they should gain from healthy end-market demand and strategic initiatives.
5 Reasons to Add Ingevity (NGVT) Stock to Your Portfolio Now
by Anindya Barman
Strong growth prospects and upbeat outlook make Ingevity (NGVT) an attractive investment option.
CE or NGVT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CE vs. NGVT: Which Stock Is the Better Value Option?
Ingevity (NGVT) Up 16% in 6 Months: What's Driving the Stock?
by Anindya Barman
Forecast-topping earnings performance and upbeat outlook have contributed to the gain in Ingevity's (NGVT) shares.
Ingevity Announces $350M Share Repurchase Authorization
by Zacks Equity Research
Ingevity (NGVT) is committed to deliver value to shareholders through share repurchase program.
Ingevity (NGVT) Beats Earnings & Revenue Estimates in Q3
by Anindya Barman
Higher demand, Georgia-Pacific pine chemicals acquisition and solid operational performance contributed to Ingevity's (NGVT) Q3 results.
What's in the Offing for AK Steel (AKS) This Earnings Season?
by Zacks Equity Research
AK Steel's (AKS) Q3 results are likely to reflect improvement in pricing and shipment.